Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

37.86 USD +0.06 (+0.16%)
Official Closing Price Updated: 7:33 PM EDT, Sep 28, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Glaxosmithkline Plc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Biotech stock reversed course lastweek, dragged lower by the broader market weakness. The week's news flow was headlined by ... 
Tags SYN PRFX APLS
From Benzinga
Better Coronavirus Stock: BioNTech or Vir Biotechnology?
Both of these biotechs have promising COVID-19 programs. But one of them appears to have a clear edge. 
Tags GSK GMAB Market News
From Motley Fool
There are four coronavirus vaccines in late-stage studies; here’s how they differ
Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so and providing additional details that can... 
Tags Medical Products BNTX PFE
From MarketWatch
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GRTS Trading Ideas NEOS
From Benzinga
A Lot Of Worriers Out There
Moderately higher US jobless numbers surprised the market which expected unemployment to fall. 
Tags Gold/Precious Metals Commodities Stocks / Equities
From Blogs - TalkMarkets
Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine
You’ve probably been wondering how the Food and Drug Administration will decide if a COVID-19 vaccine is safe and effective. 
Tags MRK MRNA AZN
From MarketWatch
Scientists examine how adults and children fight off COVID-19 — and say it may have implications for vaccine research
Vaccine candidates to protect against SARS-CoV-2 are typically aimed at neutralizing-antibodies. A new study suggests that boosting certain types of the body’s immunity may help too. 
Tags SAN BNTX Personal Finance
From MarketWatch
Analysts Anticipate FVD Will Reach $35
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Coronavirus update: Global case tally tops 30 million, and controversial CDC testing guideline changes were reportedly not made by CDC scientists
The number of confirmed cases of the coronavirus that causes COVID-19 rose above 30 million on Friday, and the death toll rose above 946,000, with the U.S. death toll edging closer to 200,000, or... 
Tags CH:ROG Pharmaceuticals SPX
From MarketWatch
Dr. Fauci: ‘We may be able to put this coronavirus outbreak behind us’ — but says the American public must play a critical role
COVID-19 has now infected more than 30 million people worldwide. 
Tags AZN COMP JNJ
From MarketWatch
Is AstraZeneca Still A Safe Bet?
Since the beginning of the pandemic, AstraZeneca (NYSE: AZN) was among the front-runners in the COVID-19 vaccine race. The company has ... 
Tags SFOSF BNTX IAM Newswire
From Benzinga
Dr. Offit: Prepare to wear masks and socially distance even after getting COVID-19 vaccine
Dr. Paul Offit, a pediatrician at Children’s Hospital of Philadelphia and a co-inventor of the rotavirus vaccine, told friends not to worry about the coronavirus. “I am on the record as being dead... 
Tags BNTX Medical Products General
From MarketWatch
Sorrento Surges On FDA Nod For Initiating Clinical Study Of COVID-19 Antibody Treatment
Sorrento Therapeutics Inc (NASDAQ: SRNE) shares, which are known for being volatile, are headed higher Thursday morning. What ... 
Tags Covid/19 Trading Ideas General
From Benzinga
Lilly's Coronavirus Antibody Treatment Found Effective, Safe In Mild-To-Moderate Patients
Eli Lilly And Co (NYSE: LLY) shares were moving higher Wednesday after the large-cap biopharma released positive proof-of-concept data ... 
Tags LLY Benzinga GSK
From Benzinga
Seattle Genetics Pact With Drug Giant Merck Sends SGEN Stock Soaring
Merck and Seattle Genetics announced a new collaboration on a treatment for cancer, a deal that includes Merck buying $1 billion in Seattle Genetics shares, sending SGEN stock soaring. 
From Investor's Business Daily
Trigger-Happy Markets Are
Today we have a buy because I think the sell-off is unlikely to continue, despite a generally bearish outlook. 
Tags Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Akouos Inc (NASDAQ: AKUS) Castle Biosciences Inc (NASDAQ: ... 
Tags RMED Earnings Offerings
From Benzinga
AstraZeneca’s coronavirus vaccine setback shows why Big Pharma would rather be safe than sorry
Before the AstraZeneca announcement about pausing vaccine trials, its chief executive and the top executives of eight other big pharmaceutical companies gave an unusual statement. 
Tags Biotechnology XX:SXXP NVAX
From MarketWatch
The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS) Albireo Pharma Inc (NASDAQ: ... 
Tags BNR Pre/Market Outlook SNY
From Benzinga
6 Companies Racing to Mass-Produce a Coronavirus Vaccine in 2021
These healthcare companies have had plenty of help in building the manufacturing capacity needed to produce billions of vaccine doses. 
Tags PFE LZAG/Y SNY
From Motley Fool
Market Briefing For Wednesday, September 9
S&P and big-cap-led Nasdaq continue cratering, not helped by the Apple hit, but particularly NDX, as the oft-warned about situation with Tesla unwinds. 
Tags Technology Energy Bonds
From Blogs - TalkMarkets
AstraZeneca Shares Drop 8% As Advanced COVID-19 Vaccine Trials Are Halted
AstraZeneca Plc (NYSE: AZN) shares tanked in the after-hours session Tuesday, as the British drugmaker said it hastemporarily ... 
Tags AZN News Benzinga
From Benzinga
As Political Pressure Mounts, COVID-19 Vaccine Developers Pledge To Put Safety First
Against the backdrop of pressure to expeditiously bring out a coronavirus vaccine as quickly as possible, biopharma companies working on ... 
Tags Market News NVAX MRK
From Benzinga
There are seven coronavirus vaccine candidates being tested in the U.S. — here’s where they stand
The race to develop a safe and effective COVID-19 vaccine is well under way, setting the stage to bring to market the fastest vaccine in history. 
Tags JNJ GSK Health/Care
From MarketWatch
Coronavirus update: Global case tally tops 27.3 million, U.S. accounts for a quarter and 9 drug maker CEOs pledge to ‘stand with science’ in developing vaccine
The number of confirmed cases of the coronavirus that causes COVID-19 climbed above 27.3 million on Tuesday with the U.S. accounting for about a quarter of that total, as a group of nine drug makers... 
Tags SNY Company Announcements/Warnings B
From MarketWatch
P/E Ratio Insights for GlaxoSmithKline
In the current market session,GlaxoSmithKline Inc. (NYSE: GSK)is trading at $39.10, after a1.62% gain. ... 
Tags News Market News P/E Ratio Insights
From Benzinga
My parents have $50,000 in credit-card debt and $50,000 in a home-equity loan. My father works part-time and my mother refuses to work. How can we help?
‘My mother seems to think they will be able to retire in three years when they get additional Social Security, but they have zero retirement funds.’ 
Tags Banks PFE General
From MarketWatch
Sanofi COVID-19 vaccine to cost below €10 and drug ingredients IPO planned within months, its France chief says
Sanofi stock rose on Monday, as a senior executive said its drugs ingredients IPO was planned for the coming months. 
Tags GSK
From MarketWatch
Some COVID-19 patients suffer lung and heart damage, but there’s encouraging news for these ‘long haulers’
Two papers presented at the European Respiratory Society International Congress on Monday examined patients who were suffering health aftereffects of coronavirus. 
Tags GSK Health/Care JNJ
From MarketWatch
Benzinga's Bulls And Bears Of The Week: Apple, Costco, FedEx And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. This past week's bullish calls ... 
Tags Top Stories AAL Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.